
Rating Quick Look | NetEase and CLOUD MUSIC target prices raised! Wall Street calls for a target of $1000.

I'm PortAI, I can summarize articles.
Bank of America believes that Eli Lilly, which rose over 60% last year and has risen 30% year-to-date, remains popular! The company's obesity drug Zepbound may become the "leader" in the obesity field in the second quarter. Given the scarcity of high-growth stories in the healthcare sector, it is expected that the stock price will continue to strengthen.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

